Tamminga RYJ - Search Results

1

Lymphadenopathy driven by TCR-V_γ8V_δ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome.

Vavassori S, Galson JD, Trück J, van den Berg A, Tamminga RYJ, Magerus-Chatinet A, Pellé O, Camenisch Gross U, Marques Maggio E, Prader S, Opitz L, Nüesch U, Mauracher A, Volkmer B, Speer O, Suda L, Röthlisberger B, Zimmermann DR, Müller R, Diepstra A, Visser L, Haralambieva E, Neven B, Rieux-Laucat F, Pachlopnik Schmid J. Vavassori S, et al. Among authors: tamminga ryj. Blood Adv. 2017 Jun 22;1(15):1101-1106. doi: 10.1182/bloodadvances.2017006411. eCollection 2017 Jun 27. Blood Adv. 2017. PMID: 29296752 Free PMC article.

2

FAS gene mutation in a case of autoimmune lymphoproliferative syndrome type IA with accumulation of gammadelta+ T cells.

van den Berg A, Tamminga R, de Jong D, Maggio E, Kamps W, Poppema S. van den Berg A, et al. Am J Surg Pathol. 2003 Apr;27(4):546-53. doi: 10.1097/00000478-200304000-00017. Am J Surg Pathol. 2003. PMID: 12657942

3

Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.

Brooimans RA, van den Berg AJ, Tamminga RY, Revesz T, Wulffraat NM, Zegers BJ. Brooimans RA, et al. Hum Mutat. 2000 Apr;15(4):386-7. doi: 10.1002/(SICI)1098-1004(200004)15:4<386::AID-HUMU24>3.0.CO;2-1. Hum Mutat. 2000. PMID: 10737997

4

The role of cytokines in the pathogenesis of pulmonary Langerhans' cell histiocytosis.

de Graaf JH, Mannes GP, Tamminga RY, Kamps WA, Timens W. de Graaf JH, et al. Adv Exp Med Biol. 1995;378:535-7. doi: 10.1007/978-1-4615-1971-3_120. Adv Exp Med Biol. 1995. PMID: 8526136 No abstract available.

5

Neutrophil antibody specificity in different types of childhood autoimmune neutropenia.

Bruin MC, von dem Borne AE, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Bruin MC, et al. Blood. 1999 Sep 1;94(5):1797-802. Blood. 1999. PMID: 10477706 Free article.

6

A long-term follow-up study of subtotal splenectomy in children with hereditary spherocytosis.

Rosman CWK, Broens PMA, Trzpis M, Tamminga RYJ. Rosman CWK, et al. Among authors: tamminga ryj. Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26592. Epub 2017 Apr 18. Pediatr Blood Cancer. 2017. PMID: 28417547

7

Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.

Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden NL, Wesseling J, Vidarsson G, Laarhoven AG, de Haas M, Bruin MCA; TIKI Investigators. Heitink-Pollé KMJ, et al. Among authors: tamminga ryj. Blood. 2018 Aug 30;132(9):883-891. doi: 10.1182/blood-2018-02-830844. Epub 2018 Jun 26. Blood. 2018. PMID: 29945954 Free article. Clinical Trial.

8

Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura.

Kanhai D, Mulder R, Ploos van Amstel HK, Schutgens R, Lukens M, Tamminga RYJ. Kanhai D, et al. Among authors: tamminga ryj. Pediatr Blood Cancer. 2018 Dec;65(12):e27418. doi: 10.1002/pbc.27418. Epub 2018 Aug 19. Pediatr Blood Cancer. 2018. PMID: 30124235

9

Rituximab treatment for symptomatic chronic ITP.

Tamminga RY, Bruin MC. Tamminga RY, et al. Pediatr Blood Cancer. 2006 Oct 15;47(5 Suppl):714-6. doi: 10.1002/pbc.20967. Pediatr Blood Cancer. 2006. PMID: 16933264 Review.

10

Longitudinal anthropometric study in children with acute lymphoblastic leukaemia.

Tamminga RY, Kamps WA, Drayer NM, Humphrey GB. Tamminga RY, et al. Acta Paediatr. 1992 Jan;81(1):61-5. doi: 10.1111/j.1651-2227.1992.tb12080.x. Acta Paediatr. 1992. PMID: 1600306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters